{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T09:05:45Z","timestamp":1772269545400,"version":"3.50.1"},"reference-count":22,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2015,4,7]],"date-time":"2015-04-07T00:00:00Z","timestamp":1428364800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0123617","type":"journal-article","created":{"date-parts":[[2015,4,7]],"date-time":"2015-04-07T18:05:02Z","timestamp":1428429902000},"page":"e0123617","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":25,"title":["The Evaluation of the Risk Factors for Non-Muscle Invasive Bladder Cancer (NMIBC) Recurrence after Transurethral Resection (TURBt) in Chinese Population"],"prefix":"10.1371","volume":"10","author":[{"given":"Shenghua","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junyao","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yishuo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengbo","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Limin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianfeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Na","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haowen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,4,7]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3322\/caac.21208","article-title":"Cancer statistics, 2014","volume":"64","author":"R Siegel","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11670-012-0001-6","article-title":"Cancer incidence and mortality in china, 2007","volume":"24","author":"WQ Chen","year":"2012","journal-title":"Chin J Cancer Res"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.eururo.2012.07.033","article-title":"Epidemiology and risk factors of urothelial bladder cancer","volume":"63","author":"M Burger","year":"2013","journal-title":"Eur Urol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1046\/j.1464-410x.1998.00628.x","article-title":"The early clinical course of primary Ta and T1 bladder cancer: a proposed prognostic index","volume":"81","author":"P Allard","year":"1998","journal-title":"Br J Urol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1016\/0959-8049(95)00287-S","article-title":"Factors affecting recurrence and progression in superficial bladder tumours","volume":"31A","author":"KH Kurth","year":"1995","journal-title":"Eur J Cancer"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.eururo.2013.06.003","article-title":"EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013","volume":"64","author":"M Babjuk","year":"2013","journal-title":"Eur Urol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/cncr.28394","article-title":"Body mass and smoking are modifiable risk factors for recurrent bladder cancer","volume":"120","author":"A Wyszynski","year":"2014","journal-title":"Cancer"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2490-14-5","article-title":"Long term follow-up in patients with initially diagnosed low grade Ta non-muscle invasive bladder tumors: tumor recurrence and worsening progression","volume":"14","author":"H Kobayashi","year":"2014","journal-title":"BMC Urol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1002\/cncr.10376","article-title":"Multivariate analysis of survival, recurrence, progression and development of mestastasis in T1 and T2a transitional cell bladder carcinoma","volume":"94","author":"A Rodriguez-Alonso","year":"2002","journal-title":"Cancer"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000355358","article-title":"The prognostic value of T1 bladder cancer substaging: a single institution retrospective study","volume":"92","author":"V Soukup","year":"2014","journal-title":"Urol Int"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1097\/01.ju.0000125486.92260.b2","article-title":"A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials","volume":"171","author":"RJ Sylvester","year":"2004","journal-title":"J Urol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1038\/bjc.2013.372","article-title":"Accuracy of the EORTC risk tables and of the CUETO scoring model to predict outcomes in non-muscle-invasive urothelial carcinoma of the bladder","volume":"109","author":"E Xylinas","year":"2013","journal-title":"Br J Cancer"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.canep.2014.02.001","article-title":"Are EORTC risk tables suitable for Chinese patients with non-muscle-invasive bladder cancer?","volume":"38","author":"W Ding","year":"2014","journal-title":"Cancer Epidemiol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.juro.2010.08.083","article-title":"Usefulness of the Spanish Urological Club for Oncological Treatment scoring model to predict nonmuscle invasive bladder cancer recurrence in patients treated with intravesical bacillus Calmette-Guerin plus interferon-alpha","volume":"185","author":"HM Rosevear","year":"2011","journal-title":"J Urol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"RJ Sylvester","year":"2006","journal-title":"Eur Urol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/j.juro.2009.07.016","article-title":"Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: the CUETO scoring model","volume":"182","author":"J Fernandez-Gomez","year":"2009","journal-title":"J Urol"},{"key":"ref17","article-title":"Histological typing of urinary bladder tumours","author":"M FK","year":"1973"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1002\/cncr.28147","article-title":"Recurrence of high-risk bladder cancer: a population-based analysis","volume":"119","author":"K Chamie","year":"2013","journal-title":"Cancer"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0090-4295(98)00461-0","article-title":"Multifocality of transitional cell carcinoma results from genetic instability of entire transitional epithelium","volume":"53","author":"A Pycha","year":"1999","journal-title":"Urology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ctrv.2009.12.005","article-title":"Intravesical therapy for superficial bladder cancer: a systematic review of randomised trials and meta-analyses","volume":"36","author":"MD Shelley","year":"2010","journal-title":"Cancer Treat Rev"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.eururo.2009.01.006","article-title":"Should all patients with non-muscle-invasive bladder cancer receive early intravesical chemotherapy after transurethral resection? The results of a prospective randomised multicentre study","volume":"55","author":"S Gudjonsson","year":"2009","journal-title":"Eur Urol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.juro.2007.08.166","article-title":"A single instillation of epirubicin after transurethral resection of bladder tumors prevents only small recurrences","volume":"179","author":"I Berrum-Svennung","year":"2008","journal-title":"J Urol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0123617","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T02:26:50Z","timestamp":1540348010000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0123617"}},"subtitle":[],"editor":[{"given":"Zhengdong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,4,7]]},"references-count":22,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,4,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0123617","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,7]]}}}